Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Allogeneic CAR T-Cells
  • 1.2.3 Autologous CAR T-Cells
• 1.3 Market by Application
  • 1.3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospital
  • 1.3.3 Diagnostic Center
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Perspective (2016-2027)
• 2.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Growth Trends by Regions
  • 2.2.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Historic Market Share by Regions (2016-2021)
  • 2.2.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Regions (2022-2027)
• 2.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Dynamic
  • 2.3.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Trends
  • 2.3.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Drivers
  • 2.3.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Challenges
  • 2.3.4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players by Revenue
  • 3.1.1 Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players by Revenue (2016-2021)
  • 3.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Players (2016-2021)
• 3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue
• 3.4 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Concentration Ratio
  • 3.4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in 2020
• 3.5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Key Players Head office and Area Served
• 3.6 Key Players Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Solution and Service
• 3.7 Date of Enter into Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Breakdown Data by Type

• 4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Historic Market Size by Type (2016-2021)
• 4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Type (2022-2027)

5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Breakdown Data by Application

• 5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Historic Market Size by Application (2016-2021)
• 5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2016-2027)
• 6.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
  • 6.2.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021)
  • 6.2.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027)
  • 6.2.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2027)
• 6.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
  • 6.3.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021)
  • 6.3.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027)
  • 6.3.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2027)
• 6.4 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
  • 6.4.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2016-2021)
  • 6.4.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2016-2027)
• 7.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
  • 7.2.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021)
  • 7.2.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027)
  • 7.2.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2027)
• 7.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
  • 7.3.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021)
  • 7.3.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027)
  • 7.3.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2027)
• 7.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
  • 7.4.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2016-2021)
  • 7.4.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2016-2027)
• 8.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
  • 8.2.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
  • 8.3.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region
  • 8.4.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2016-2027)
• 9.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
  • 9.2.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021)
  • 9.2.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027)
  • 9.2.3 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2027)
• 9.3 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
  • 9.3.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021)
  • 9.3.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027)
  • 9.3.3 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2027)
• 9.4 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
  • 9.4.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2016-2021)
  • 9.4.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2016-2027)
• 10.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
  • 10.2.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
  • 10.3.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
  • 10.4.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Pfizer
  • 11.1.1 Pfizer Company Details
  • 11.1.2 Pfizer Business Overview
  • 11.1.3 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
  • 11.1.4 Pfizer Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
  • 11.1.5 Pfizer Recent Development
• 11.2 Novartis
  • 11.2.1 Novartis Company Details
  • 11.2.2 Novartis Business Overview
  • 11.2.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
  • 11.2.4 Novartis Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
  • 11.2.5 Novartis Recent Development
• 11.3 Bristol Myers Squibb
  • 11.3.1 Bristol Myers Squibb Company Details
  • 11.3.2 Bristol Myers Squibb Business Overview
  • 11.3.3 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
  • 11.3.4 Bristol Myers Squibb Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
  • 11.3.5 Bristol Myers Squibb Recent Development
• 11.4 Legend Biotech
  • 11.4.1 Legend Biotech Company Details
  • 11.4.2 Legend Biotech Business Overview
  • 11.4.3 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
  • 11.4.4 Legend Biotech Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
  • 11.4.5 Legend Biotech Recent Development
• 11.5 Sorrento Therapeutics
  • 11.5.1 Sorrento Therapeutics Company Details
  • 11.5.2 Sorrento Therapeutics Business Overview
  • 11.5.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
  • 11.5.4 Sorrento Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
  • 11.5.5 Sorrento Therapeutics Recent Development
• 11.6 CARSGEN Therapeutics，Ltd
  • 11.6.1 CARSGEN Therapeutics，Ltd Company Details
  • 11.6.2 CARSGEN Therapeutics，Ltd Business Overview
  • 11.6.3 CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
  • 11.6.4 CARSGEN Therapeutics，Ltd Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
  • 11.6.5 CARSGEN Therapeutics，Ltd Recent Development
• 11.7 Juno Therapeutics
  • 11.7.1 Juno Therapeutics Company Details
  • 11.7.2 Juno Therapeutics Business Overview
  • 11.7.3 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
  • 11.7.4 Juno Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
  • 11.7.5 Juno Therapeutics Recent Development
• 11.8 Kite Pharma
  • 11.8.1 Kite Pharma Company Details
  • 11.8.2 Kite Pharma Business Overview
  • 11.8.3 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
  • 11.8.4 Kite Pharma Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
  • 11.8.5 Kite Pharma Recent Development
• 11.9 Atara Biotherapeutics
  • 11.9.1 Atara Biotherapeutics Company Details
  • 11.9.2 Atara Biotherapeutics Business Overview
  • 11.9.3 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
  • 11.9.4 Atara Biotherapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
  • 11.9.5 Atara Biotherapeutics Recent Development
• 11.10 Carina Biotech
  • 11.10.1 Carina Biotech Company Details
  • 11.10.2 Carina Biotech Business Overview
  • 11.10.3 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
  • 11.10.4 Carina Biotech Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
  • 11.10.5 Carina Biotech Recent Development
• 11.11 Guangzhou Xiangxue Pharmaceutical
  • 11.11.1 Guangzhou Xiangxue Pharmaceutical Company Details
  • 11.11.2 Guangzhou Xiangxue Pharmaceutical Business Overview
  • 11.11.3 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
  • 11.11.4 Guangzhou Xiangxue Pharmaceutical Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
  • 11.11.5 Guangzhou Xiangxue Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer